Among various cytokines and chemokines, serum CCL5 and CXCL10 have been linked to hot immune features, and patients with advanced HCC and high CCL5 and CXCL10 levels could experience greater benefit from ICI therapy.15 This evidence concerns the gene CCL5 and hepatocellular carcinoma.